209 related articles for article (PubMed ID: 15979945)
1. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
Ferraro TN; Buono RJ
Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945
[TBL] [Abstract][Full Text] [Related]
2. The potential of pharmacogenetics in the treatment of epilepsy.
Depondt C
Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
[TBL] [Abstract][Full Text] [Related]
3. Refractory epilepsy: clinical overview.
French JA
Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics in neuropsychiatric diseases: epilepsy as a model.
Depondt C
Acta Neurol Belg; 2006 Dec; 106(4):157-67. PubMed ID: 17323833
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
Anderson GD
Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
[TBL] [Abstract][Full Text] [Related]
6. Update on pharmacogenetics in epilepsy: a brief review.
Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ
Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995
[TBL] [Abstract][Full Text] [Related]
7. Defining the clinical role of pharmacogenetics in antiepileptic drug therapy.
Dlugos DJ; Buono RJ; Ferraro TN
Pharmacogenomics J; 2006; 6(6):357-9. PubMed ID: 16505830
[No Abstract] [Full Text] [Related]
8. [Pharmacogenetics, pharmacogenomics and individualised antiepileptic therapy].
Herranz JL
Rev Neurol; 2006 Oct; 43 Suppl 1():S43-9. PubMed ID: 17061195
[TBL] [Abstract][Full Text] [Related]
9. Polygenic epilepsy.
Ferraro TN; Buono RJ
Adv Neurol; 2006; 97():389-98. PubMed ID: 16383150
[TBL] [Abstract][Full Text] [Related]
10. [Genetic aspects of epilepsy].
Gandelman-Marton R; Neufeld MY
Harefuah; 2008 Feb; 147(2):139-44, 182. PubMed ID: 18357672
[TBL] [Abstract][Full Text] [Related]
11. Plasticity of antiepileptic drug targets.
Beck H
Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
[TBL] [Abstract][Full Text] [Related]
12. Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy.
Ferraro TN; Dlugos DJ; Buono RJ
Pharmacogenomics; 2006 Jan; 7(1):89-103. PubMed ID: 16354127
[TBL] [Abstract][Full Text] [Related]
13. Prospects for novel antiepileptic drugs.
Avanzini G; Franceschetti S
Curr Opin Investig Drugs; 2003 Jul; 4(7):805-14. PubMed ID: 14619401
[TBL] [Abstract][Full Text] [Related]
14. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
Ebid AH; Ahmed MM; Mohammed SA
Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics and epilepsy: the road ahead.
Cavalleri GL; McCormack M; Alhusaini S; Chaila E; Delanty N
Pharmacogenomics; 2011 Oct; 12(10):1429-47. PubMed ID: 22008048
[TBL] [Abstract][Full Text] [Related]
18. Monitoring gene changes during antiepileptic drug therapy to widen the safety window and reduce pharmacoresistance.
Glauser TA
Epilepsia; 2007; 48 Suppl 1():19-25. PubMed ID: 17316409
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of epilepsy: new armamentarium, new issues.
Vajda FJ
J Clin Neurosci; 2007 Sep; 14(9):813-23. PubMed ID: 17618119
[TBL] [Abstract][Full Text] [Related]
20. Genetics of epilepsy.
Pandolfo M
Semin Neurol; 2011 Nov; 31(5):506-18. PubMed ID: 22266888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]